Cerebral aneurysm, nonruptured

I9_ANEURYSM

brain aneurysm: A congenital or acquired aneurysm within the cranium.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I67.1 Hospital discharge: ICD-9 — 4373 Cause of death: ICD-10 — I67.1 Cause of death: ICD-9 — 4373 2 out of 7 registries used, show all original rules.	3390
4. Check minimum number of events None	3390
5. Include endpoints None	3390
6. Filter based on genotype QC (FinnGen only)	3390

Control definitions (FinnGen only)

Control exclude: I9_CEREBVASC

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: I67
Name in latin: Aneurysma encephali non ruptum

NAME	I9_ANEURYSM
CONTROL_EXCLUDE	I9_CEREBVASC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I671
HD_ICD_9	4373
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I671
COD_ICD_9	4373
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Cerebral aneurysm, nonruptured based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	17142	10253	6792
Only index persons	15532	9499	6033
Unadjusted period prevalence (%)
Whole population	0.25	0.29	0.19
Only index persons	0.30	0.35	0.23
Median age at first event (years)
Whole population	59.51	60.10	58.55
Only index persons	58.88	59.32	58.18

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3390	2189	1201
Unadjusted period prevalence (%)	0.67	0.75	0.53
Median age at first event (years)	58.09	57.53	59.10

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3084: Matched controls
30839

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

+∞

323.0

1058

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

151.2

323.0

474

AA1AD

NOMESCO Finland

CT of head and brain

6.1

323.0

1415

3739

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

77.8

323.0

572

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

652.7

323.0

496

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

813.7

323.0

697

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

4503599627370496.0

323.0

2963

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

196.2

323.0

394

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

3238.6

320.2

304

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

1040.5

294.6

284

PA2LT

NOMESCO Finland

Endovascular closure of extensive brain aneurysm

+∞

269.8

255

I60.1

ICD-10 Finland

Subarachnoid haemorrhage from middle cerebral artery

+∞

216.2

205

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

1038.9

201.3

195

B01AC04

ATC

clopidogrel; oral

4.8

198.1

769

2005

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

74.5

183.5

209

PA2KT

NOMESCO Finland

Endovascular closure of brain aneurysm

+∞

181.0

172

PA2AC

NOMESCO Finland

Cerebral angiography with X-ray

623.5

180.5

177

PA3AC

NOMESCO Finland

Carotis angiography with X-ray

358.5

171.0

171

AAL00

NOMESCO Finland

Endovascular occlusion of intracranial aneurysm

+∞

170.4

162

PA2YT

NOMESCO Finland

Cerebral artery PTA with stent

+∞

170.4

162

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

5.8

166.4

520

1044

4373A

ICD-9 Finland

Other and ill-defined cerebrovascular disease, Cerebral aneurysm, nonruptured

+∞

160.8

153

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

5.7

156.4

494

1000

R51.80

ICD-10 Finland

Headache

4.0

155.9

738

2266

2161

FHL

Neck ligation, big brain

+∞

134.3

128

PA2MT

NOMESCO Finland

Endovascular closure of very extensive brain aneurysm

+∞

132.2

126

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

9.2

127.7

279

328

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

3.3

122.1

745

2739

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

8.2

115.5

272

361

I60.2

ICD-10 Finland

Subarachnoid haemorrhage from anterior communicating artery

+∞

115.3

110

AA9CW

NOMESCO Finland

153.3

112.0

118

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

380.7

111.1

111

I60.0

ICD-10 Finland

Subarachnoid haemorrhage from carotid siphon and bifurcation

+∞

110.0

105

K90

ICPC

Stroke/cerebrovascular accident

36.6

108.4

140

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

43.7

104.5

130

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

957.2

95.5

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

4.7

95.4

350

814

I60.7

ICD-10 Finland

Subarachnoid haemorrhage from intracranial artery, unspecified

+∞

95.3

AAF00

NOMESCO Finland

Ventriculostomy

67.4

85.0

4300A

ICD-9 Finland

Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOID. POST ANEURYSMA SACCULARE]

+∞

81.6

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

100.6

80.3

PA4AC

NOMESCO Finland

Vertebralis angiography with X-ray

278.1

79.9

XA800

NOMESCO Finland

Neuropsychological investigation

6.4

79.0

218

361

PA2AD

NOMESCO Finland

CT angiography of brain

37.2

78.7

101

N03AB02

ATC

phenytoin; systemic

19.7

77.1

118

R42

ICD-10 Finland

Dizziness and giddiness

2.4

77.0

792

3857

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

376.2

74.0

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.9

73.5

523

2057

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

735.4

73.5

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.5

72.9

378

1189

I10

ICD-10 Finland

Essential (primary) hypertension

2.0

70.3

1893

13753

PA2AG

NOMESCO Finland

Restrected MRI examination of vessels in the head with high intensity magnet

59.4

69.0

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.7

68.9

545

2280

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

4.6

67.2

246

565

K91

ICPC

Cerebrovascular disease

28.0

65.6

G44.2

ICD-10 Finland

Tension-type headache

2.6

65.3

532

2258

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

18.3

64.4

101

AA5PD

NOMESCO Finland

CT examination of brain pefusion

52.6

64.3

I60.3

ICD-10 Finland

Subarachnoid haemorrhage from posterior communicating artery

+∞

62.7

WX882

NOMESCO Finland

High dependency care

6.6

60.3

161

254

ZXE10

NOMESCO Finland

More than one and less than three hours

1.9

59.0

1221

7852

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

5.7

56.8

171

315

N02BE01

ATC

paracetamol; systemic, rectal

2.3

56.2

2702

23340

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

90.4

56.1

205

Kela drug reimbursment

Chronic hypertension

2.0

55.1

926

5473

PA2CG

NOMESCO Finland

Extensive MRI examination of vessels in the head with high intensity magnet

32.5

53.1

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

6.0

52.8

151

261

XCK00

NOMESCO Finland

Perimetry

3.3

52.7

291

951

H53.4

ICD-10 Finland

Visual field defects

8.3

52.1

119

149

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

179.7

51.0

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

506.0

50.6

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

10.3

50.3

101

I60.6

ICD-10 Finland

Subarachnoid haemorrhage from other intracranial arteries

+∞

50.1

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

50.0

1367

9495

ZXE20

NOMESCO Finland

More than three and less than five hours

2.4

48.8

480

2225

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

+∞

48.0

Z2445

NOMESCO Finland

Psychologist

5.2

47.9

155

311

ZXM40

NOMESCO Finland

Use of fluorescent substance

68.6

47.2

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

+∞

47.0

PA7BD

NOMESCO Finland

CT angiography of neck and brain

8.7

46.7

103

122

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

46.0

879

5373

I60.4

ICD-10 Finland

Subarachnoid haemorrhage from basilar artery

+∞

45.9

N03AX14

ATC

levetiracetam; systemic

6.2

45.3

126

210

I63.8

ICD-10 Finland

Other cerebral infarction

84.8

45.0

C10AA05

ATC

atorvastatin; oral

1.8

43.8

1179

8044

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

14.3

43.2

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

15.8

43.2

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

6.1

42.9

120

202

C08CA01

ATC

amlodipine; oral

1.8

42.8

1108

7452

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

6.7

42.2

111

172

XX4AW

NOMESCO Finland

79.6

42.0

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.9

41.9

179

474

H53.1

ICD-10 Finland

Subjective visual disturbances

3.0

41.9

256

896

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

8.1

41.7

122

ZXD05

NOMESCO Finland

Urgent procedure

1.8

41.4

923

5905

H53.2

ICD-10 Finland

Diplopia

4.9

41.2

141

301

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.1

41.2

244

833

N03AF02

ATC

oxcarbazepine; oral

4.7

39.1

137

300

N03AF01

ATC

carbamazepine; oral, rectal

3.3

38.5

208

667

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

3.1

38.1

223

757

TAB00

NOMESCO Finland

Lumbar puncture

3.6

37.6

176

504

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

21.5

37.4

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

5.4

37.2

115

219

G91.0

ICD-10 Finland

Communicating hydrocephalus

22.0

37.0

C07AB07

ATC

bisoprolol; oral

1.6

35.7

1397

10413

I67.0

ICD-10 Finland

Dissection of cerebral arteries, nonruptured

+∞

35.5

R4150

NOMESCO Finland

Neuropsychological rehabilitation

19.2

34.8

I72.0

ICD-10 Finland

Aneurysm and dissection of carotid artery

182.0

34.8

G40.9

ICD-10 Finland

Epilepsy, unspecified

4.4

34.2

127

295

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

9.6

32.5

N18

ICPC

Paralysis/weakness

8.2

32.3

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

5.3

31.8

191

R20.2

ICD-10 Finland

Paraesthesia of skin

2.7

31.7

230

893

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

+∞

31.3

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.9

30.8

503

2849

R51

ICD-10 Finland

Headache

3.0

30.7

186

643

ZXD35

NOMESCO Finland

Usual procedure

3.6

30.0

141

406

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.5

29.8

143

419

43090

ICD-8 Finland

Subarachnoid haemorrhage, Postaneurysma sacculare, hypertonia non indicata

+∞

29.2

AA1AM

NOMESCO Finland

Short MRI examination of brain with 3 Tesla magnet

22.4

29.1

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

5.5

28.7

159

C10AA01

ATC

simvastatin; oral

1.5

28.3

1258

9491

Q28.3

ICD-10 Finland

Other malformations of cerebral vessels

20.3

28.2

C07AB02

ATC

metoprolol; systemic

1.8

27.9

613

3824

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

27.9

1147

8483

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.3

27.8

266

1198

G43.9

ICD-10 Finland

Migraine, unspecified

2.9

27.6

174

618

N03AG01

ATC

valproic acid; systemic, rectal

2.7

27.0

195

754

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

26.7

452

2584

B01AC07

ATC

dipyridamole; systemic

3.9

26.6

114

304

I62.0

ICD-10 Finland

Nontraumatic subdural haemorrhage

+∞

26.1

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

3.0

26.0

159

554

C08CA06

ATC

nimodipine; systemic

262.7

25.7

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

25.2

1356

10588

N02AX02

ATC

tramadol; systemic, rectal

1.5

24.8

1230

9418

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

131.1

24.6

WX892

NOMESCO Finland

Monitored bed care

2.4

24.0

220

968

B01AA03

ATC

warfarin; systemic

1.8

23.7

494

3017

PA6AG

NOMESCO Finland

Limited MRI examination of neck vasculature with high intensity magnet

16.0

23.6

Z3231

NOMESCO Finland

Registered nurse

1.6

23.6

780

5420

Q61.3

ICD-10 Finland

Polycystic kidney, unspecified

14.0

23.5

N06AX11

ATC

mirtazapine; oral

1.5

23.3

910

6576

315

Kela drug reimbursment

Clopidogrel

10.6

22.8

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

3.9

22.7

249

Q28.2

ICD-10 Finland

Arteriovenous malformation of cerebral vessels

26.1

22.6

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.2

22.3

239

1135

PA2BM

NOMESCO Finland

MRI examination of vessels in the head with 3 Tesla magnet

63.0

21.9

I69.8

ICD-10 Finland

Sequelae of other and unspecified cerebrovascular diseases

63.0

21.9

R4120

NOMESCO Finland

Occupational therapy

2.5

21.8

177

730

N06AB04

ATC

citalopram; systemic

1.6

21.7

628

4203

N07BA03

ATC

varenicline; oral

2.6

21.6

166

666

R55

ICD-10 Finland

Syncope and collapse

2.0

21.5

294

1546

I67.2

ICD-10 Finland

Cerebral atherosclerosis

50.4

21.1

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.3

21.1

212

978

Z3226

NOMESCO Finland

Physiotherapist

1.7

21.1

524

3362

I69.2

ICD-10 Finland

Sequelae of other nontraumatic intracranial haemorrhage

+∞

20.9

G46.3*I67.9

ICD-10 Finland

Brain stem stroke syndrome (I60-I67+)

+∞

20.9

N01

ICPC

Headache

2.1

20.8

258

1307

I60.8

ICD-10 Finland

Other subarachnoid haemorrhage

211.3

20.6

PAN14

NOMESCO Finland

Plastic repair of arteries internal carotid artery

110.8

20.6

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

3.0

20.6

124

430

R1260

NOMESCO Finland

Evaluation of communicative skills

5.8

20.5

101

C09AA05

ATC

ramipril; oral

1.6

19.9

654

4504

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

19.9

611

4139

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.9

19.9

325

1826

4309X

ICD-9 Finland

Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOIDALIS NUD]

+∞

19.8

Z82.3

ICD-10 Finland

Family history of stroke

15.4

19.7

PA6AD

NOMESCO Finland

CT of neck arteries

6.8

19.5

C09AA02

ATC

enalapril; systemic

1.6

19.3

551

3661

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

4.0

19.3

194

A02BC03

ATC

lansoprazole; oral

1.5

19.2

854

6300

C09CA01

ATC

losartan; oral

1.5

19.2

681

4778

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.3

19.0

177

786

ZXA00

NOMESCO Finland

Right side

1.5

19.0

782

5669

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.5

19.0

158

664

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

19.0

311

1749

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

6.5

19.0

G45.3

ICD-10 Finland

Amaurosis fugax

4.3

19.0

164

G81.9

ICD-10 Finland

Hemiplegia, unspecified

7.1

18.8

TPH07

NOMESCO Finland

Cathetrisation of artery

1.9

18.8

292

1609

4380A

ICD-9 Finland

Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]

+∞

18.8

PA7CC

NOMESCO Finland

Very extensive angiography of arteries of neck and brain

100.7

18.6

AAL10

NOMESCO Finland

Intracranial endovascular thrombolysis

191.1

18.5

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

18.5

781

5690

N05AH04

ATC

quetiapine; oral

1.7

18.2

419

2623

N06AB10

ATC

escitalopram; oral

1.6

18.1

515

3415

XX1ZW

NOMESCO Finland

Very extensive written report from radiologist

13.0

17.9

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.1

17.9

208

1023

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

5.8

17.8

N05CF01

ATC

zopiclone; oral

1.5

17.8

903

6825

R53

ICD-10 Finland

Malaise and fatigue

1.6

17.8

540

3639

R47.0

ICD-10 Finland

Dysphasia and aphasia

11.1

17.7

R4110

NOMESCO Finland

Physiotherapy

1.5

17.5

727

5266

N06AA09

ATC

amitriptyline; systemic

1.8

17.5

316

1832

I64

ICD-10 Finland

Stroke, not specified as haemorrhage or infarction

28.9

17.4

WW200

SPAT

1.8

17.3

300

1716

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

17.2

572

3939

C09CA06

ATC

candesartan; oral

1.5

17.1

626

4404

Z00.0

ICD-10 Finland

General medical examination

1.6

17.0

495

3293

TPX22

NOMESCO Finland

Intravenous arterial thrombolysis

25.7

16.9

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

16.7

223

1160

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.9

16.7

249

1352

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

16.7

594

4150

I67.6

ICD-10 Finland

Nonpyogenic thrombosis of intracranial venous system

+∞

16.7

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

6.9

16.7

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.6

16.6

540

3695

NK6AI

NOMESCO Finland

Other cone beam scan

27.7

16.5

R03BB04

ATC

tiotropium bromide; inhalant

1.9

16.4

271

1525

R41.0

ICD-10 Finland

Disorientation, unspecified

3.2

16.3

279

N03AX12

ATC

gabapentin; oral

1.6

16.3

442

2888

R06.0

ICD-10 Finland

Dyspnoea

1.5

16.1

662

4769

N05BA01

ATC

diazepam; systemic, rectal

1.7

16.0

375

2355

N06AX16

ATC

venlafaxine; oral

1.7

15.9

379

2389

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.9

15.9

256

1430

WX872

NOMESCO Finland

Intensive care

2.4

15.8

136

580

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.2

15.8

172

823

H93.1

ICD-10 Finland

Tinnitus

2.0

15.7

198

1008

I60.5

ICD-10 Finland

Subarachnoid haemorrhage from vertebral artery

+∞

15.6

I61.8

ICD-10 Finland

Other intracerebral haemorrhage

+∞

15.6

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

15.6

561

3925

H02AB06

ATC

prednisolone; systemic

1.4

15.5

1298

10675

N19

ICPC

Speech disorder

6.9

15.4

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

4.6

15.4

117

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.8

15.4

304

1812

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

15.4

800

6043

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.2

15.2

164

782

SPAT1216

SPAT

Assessment of functional ability

1.6

15.2

404

2621

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

15.2

575

4065

A02BC02

ATC

pantoprazole; systemic

1.4

15.1

1854

16203

Z72.0

ICD-10 Finland

Tobacco use

3.2

15.0

252

M54.5

ICD-10 Finland

Low back pain

1.4

15.0

882

6812

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

15.0

741

5541

N05BA04

ATC

oxazepam; oral

1.5

14.9

682

5015

M03BX02

ATC

tizanidine; oral

1.4

14.9

1769

15359

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

7.0

14.8

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

4.3

14.8

131

M79.6

ICD-10 Finland

Pain in limb

1.4

14.8

984

7765

N03AX16

ATC

pregabalin; oral

1.5

14.8

656

4793

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

14.7

443

2968

I72.8

ICD-10 Finland

Aneurysm and dissection of other specified arteries

10.5

14.7

Z2446

NOMESCO Finland

Social worker

2.1

14.6

165

804

4340A

ICD-9 Finland

Occlusion of cerebral arteries, Cerebral thrombosis

+∞

14.6

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.1

14.6

277

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

14.5

931

7294

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.5

14.4

118

492

R11

ICD-10 Finland

Nausea and vomiting

1.9

14.4

209

1124

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

7.9

14.3

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

14.2

1003

7981

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

14.2

802

6139

XX3DW

NOMESCO Finland

Time consuming IT work

1.7

14.1

292

1769

C08CA13

ATC

lercanidipine; oral

1.6

14.1

368

2379

Z71.8

ICD-10 Finland

Other specified counselling

1.5

13.9

596

4319

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

6.1

13.9

N03AX11

ATC

topiramate; oral

3.1

13.9

250

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

13.8

210

1148

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

13.8

439

2978

C03CA01

ATC

furosemide; systemic

1.4

13.8

683

5092

C08CA05

ATC

nifedipine; systemic

2.0

13.8

176

902

W19

ICD-10 Finland

Unspecified fall

1.8

13.7

233

1324

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.4

13.7

193

I61.5

ICD-10 Finland

Intracerebral haemorrhage, intraventricular

+∞

13.5

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

8.4

13.5

S18

ICPC

Laceration/cut

1.3

13.3

1164

9564

SPAT1153

SPAT

Removal of sutures

1.4

13.3

895

7047

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

9.7

13.2

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

6.9

13.1

UJF32

NOMESCO Finland

Coloscopy

1.4

13.1

696

5256

P20

ICPC

Memory disturbance

1.7

12.9

286

1762

AN1

Coronary angiography

1.7

12.8

292

1815

A06AD11

ATC

lactulose; oral

1.6

12.8

351

2292

M03BX01

ATC

baclofen; systemic

3.6

12.7

162

ICD-10 Finland

2.7

12.7

320

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

12.6

335

2169

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.2

12.6

124

570

I65.0

ICD-10 Finland

Occlusion and stenosis of vertebral artery

+∞

12.5

PA7KT

NOMESCO Finland

Temporary closure of brain artery

+∞

12.5

G46.4*I67.9

ICD-10 Finland

Cerebellar stroke syndrome

+∞

12.5

I62.1

ICD-10 Finland

Nontraumatic extradural haemorrhage

+∞

12.5

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

12.5

312

1992

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.3

12.5

115

513

N03AE01

ATC

clonazepam; systemic

2.0

12.3

159

820

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

2.6

12.3

356

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.3

12.2

110

484

C02AC05

ATC

moxonidine; oral

2.2

12.2

125

583

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.0

12.1

149

754

J01MA02

ATC

ciprofloxacin; systemic

1.3

12.1

1034

8431

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

12.1

620

4639

Z94.0

ICD-10 Finland

Kidney transplant status

4.2

12.1

109

N03AX09

ATC

lamotrigine; oral

2.2

12.0

120

555

SPAT1229

SPAT

Assessment of need for aid

1.8

12.0

201

1137

A28

ICPC

Limited function/disability NOS

1.6

12.0

351

2330

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.9

12.0

168

892

S06.0

ICD-10 Finland

Concussion

1.7

12.0

249

1509

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.9

11.8

164

868

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.1

11.8

132

642

ZYC01

SPAT

2.0

11.7

143

719

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.5

11.7

361

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

11.6

777

6085

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

3.3

11.6

180

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

12.6

11.6

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

12.6

11.6

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

11.6

388

2660

AAB30

NOMESCO Finland

Evacuation of spontaneous intracranial haematoma

+∞

11.5

I65.3

ICD-10 Finland

Occlusion and stenosis of multiple and bilateral precerebral arteries

+∞

11.5

43099

ICD-8 Finland

Subarachnoid haemorrhage, Without mention of hypertension

+∞

11.5

AAC20

NOMESCO Finland

Anastomosis to intracranial vessel

+∞

11.5

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

11.3

435

3073

R51.81

ICD-10 Finland

Facial pain NOS

2.7

11.2

274

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

11.2

426

3001

N17

ICPC

Vertigo/dizziness

1.6

11.2

269

1700

A02BC05

ATC

esomeprazole; systemic

1.3

11.1

1129

9420

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

11.0

297

1933

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.8

11.0

190

1085

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

4.0

11.0

105

R50.9

ICD-10 Finland

Fever, unspecified

1.5

11.0

338

2270

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

3.9

11.0

110

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

10.9

366

2506

WX730

NOMESCO Finland

Conventional respirator

3.6

10.8

131

A02BC01

ATC

omeprazole; systemic

1.4

10.8

742

5827

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.4

10.8

374

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

10.8

437

3117

SPAT1310

SPAT

Counselling related to known health issue

1.3

10.8

844

6765

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

5.4

10.7

C08CA02

ATC

felodipine; oral

1.7

10.7

237

1461

R4130

NOMESCO Finland

Speech therapy

3.3

10.7

154

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

4.5

10.6

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

10.6

1041

8623

I69

ICD-10 Finland

Sequelae of cerebrovascular disease

60.2

10.6

SPAT1301

SPAT

No procedures

1.3

10.6

832

6671

J01DB01

ATC

cefalexin; oral

1.3

10.6

2328

21529

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.6

10.6

126

2184

ZXY02

NOMESCO Finland

Neuropsychologist

6.5

10.5

WX704

NOMESCO Finland

Intubation

1.8

10.5

191

1114

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

10.4

535

3994

PA7RT

NOMESCO Finland

Medical infusion to cerebral artery

110.4

10.4

J67.1

ICD-10 Finland

Bagassosis

+∞

10.4

G40.10

ICD-10 Finland

Simple partial seizures

5.9

10.4

G44.0

ICD-10 Finland

Cluster headache syndrome

4.1

10.4

H47.2

ICD-10 Finland

Optic atrophy

7.7

10.4

AAK00

NOMESCO Finland

Cranioplasty

32.6

10.3

WX110

NOMESCO Finland

Local anesthesy

1.3

10.3

1868

16777

N05BA09

ATC

clobazam; oral

8.2

10.3

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

10.3

241

1510

J01AA02

ATC

doxycycline; systemic

1.3

10.2

2269

20935

N30.0

ICD-10 Finland

Acute cystitis

1.5

10.2

345

2368

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

10.2

279

1824

J01DA01

ATC

[U] cefalexin; systemic

1.3

10.0

1727

15382

N06AX21

ATC

duloxetine; oral

1.6

10.0

278

1822

ZXA05

NOMESCO Finland

Left side

1.4

9.9

667

5210

R04.0

ICD-10 Finland

Epistaxis

1.8

9.9

174

1002

C10AX09

ATC

ezetimibe; oral

1.6

9.9

280

1843

J01EA01

ATC

trimethoprim; systemic

1.4

9.8

650

5067

G44.8

ICD-10 Finland

Other specified headache syndromes

3.8

9.8

107

J01FA06

ATC

roxithromycin; oral

1.3

9.8

1090

9168

S22.3

ICD-10 Finland

Fracture of rib

1.8

9.7

159

892

G50.1

ICD-10 Finland

Atypical facial pain

2.9

9.7

193

G50.0

ICD-10 Finland

Trigeminal neuralgia

3.0

9.6

178

127

Kela drug reimbursment

Transplant complication

3.2

9.6

156

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.8

9.6

207

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.7

9.5

225

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

3.5

9.5

120

C10AA07

ATC

rosuvastatin; oral

1.4

9.5

634

4949

PA6YT

NOMESCO Finland

Dilatation of carotid artery with stent

100.3

9.4

I62.9

ICD-10 Finland

Intracranial haemorrhage (nontraumatic), unspecified

+∞

9.4

PA2VT

NOMESCO Finland

Intravascular evacuation of brain artery embolus

+∞

9.4

I67.7

ICD-10 Finland

Cerebral arteritis, not elsewhere classified

+∞

9.4

H49.1

ICD-10 Finland

Fourth [trochlear] nerve palsy

6.2

9.4

C09BA02

ATC

enalapril and diuretics; systemic

1.6

9.3

222

1397

C03AA03

ATC

hydrochlorothiazide; oral

1.6

9.3

253

1651

H02AB04

ATC

methylprednisolone; systemic

1.4

9.3

392

2815

M48.0

ICD-10 Finland

Spinal stenosis

1.5

9.3

303

2065

P01AB01

ATC

metronidazole; oral, rectal

1.3

9.2

1063

8958

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

9.2

276

1840

N05CD07

ATC

temazepam; oral

1.5

9.2

308

2106

A12BA01

ATC

potassium chloride; oral

2.0

9.2

109

545

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

3.1

9.2

156

W10

ICD-10 Finland

Fall on and from stairs and steps

1.9

9.2

124

655

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

9.1

172

1013

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.9

9.1

127

674

N02AA05

ATC

oxycodone; systemic

1.5

9.1

349

2456

R03AC02

ATC

salbutamol; inhalant

1.3

9.1

1399

12221

G51.0

ICD-10 Finland

Bell palsy

2.4

9.1

299

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.5

9.1

308

2116

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.9

9.0

121

637

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.9

9.0

180

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.1

9.0

462

I95.1

ICD-10 Finland

Orthostatic hypotension

2.3

9.0

333

I67.8

ICD-10 Finland

Other specified cerebrovascular diseases

18.6

8.9

B01AC22

ATC

prasugrel; oral

7.4

8.9

ZXH09

SPAT

2.8

8.9

203

SPAT1252

SPAT

Overall medication plan or its review

1.7

8.8

176

1054

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

8.8

1008

8474

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.7

8.8

171

1018

R52.2

ICD-10 Finland

Other chronic pain

2.2

8.8

403

H02.4

ICD-10 Finland

Ptosis of eyelid

2.3

8.8

350

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

8.8

244

1598

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

8.8

512

3901

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.6

8.8

233

1509

SPAT1053

SPAT

Memory test

1.5

8.7

339

2395

H34.1

ICD-10 Finland

Central retinal artery occlusion

5.9

8.7

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.6

8.7

233

SPAT1240

SPAT

Therapeutic discussion

1.6

8.7

229

1482

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.4

8.6

277

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.0

8.6

107

547

S01.0

ICD-10 Finland

Open wound of scalp

1.7

8.6

165

977

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

8.6

273

1850

SPAT1254

SPAT

Administration of medicine

1.5

8.5

331

2339

EBA00

NOMESCO Finland

Extraction of tooth

1.3

8.5

796

6514

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

8.4

158

930

R07.3

ICD-10 Finland

Other chest pain

1.6

8.3

235

1546

AAC10

NOMESCO Finland

Reinforcement of intracranial aneurysm wall

+∞

8.3

I60

ICD-10 Finland

Subarachnoid haemorrhage

+∞

8.3

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

8.3

194

1214

SPAT1284

SPAT

Extensive health certificate

2.3

8.3

309

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

8.3

297

2065

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.5

8.3

108

M54.2

ICD-10 Finland

Cervicalgia

1.7

8.3

179

1101

SPAT1210

SPAT

Application of cast or individual aid

1.9

8.2

112

592

M79.1

ICD-10 Finland

Myalgia

1.5

8.2

302

2109

G40

ICD-10 Finland

Epilepsy

4.4

8.2

F06.7

ICD-10 Finland

Mild cognitive disorder

2.5

8.2

247

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

8.2

475

3612

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

8.1

469

3564

N06AX03

ATC

mianserin; oral

1.8

8.1

126

699

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.4

8.0

381

2797

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

8.0

294

2053

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

8.0

688

5553

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.7

8.0

144

840

C07AA05

ATC

propranolol; systemic

1.4

8.0

489

3752

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.2

8.0

369

JN3AD

NOMESCO Finland

Abdominal CT examination

1.6

7.9

193

1223

SPAT1101

SPAT

Orthostatic test

2.0

7.9

103

536

XX4BW

NOMESCO Finland

13.0

7.9

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

5.1

7.8

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.6

7.8

186

1171

R13

ICD-10 Finland

Dysphagia

1.7

7.8

158

951

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

5.7

7.8

183

Kela drug reimbursment

Lamotrigin and topiramate

4.3

7.8

C03DA01

ATC

spironolactone; oral

1.5

7.8

242

1632

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.8

7.7

133

764

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.0

7.7

493

N28

ICPC

Limited function/disability (N)

3.1

7.7

131

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

3.2

7.7

120

C09DA06

ATC

candesartan and diuretics; oral

1.6

7.7

194

1242

G44.1

ICD-10 Finland

Vascular headache, not elsewhere classified

4.6

7.7

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

7.7

214

1407

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.7

7.6

190

J01CA04

ATC

amoxicillin; systemic

1.3

7.5

2221

20708

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

7.5

126

719

L02

ICPC

Back symptom/complaint

1.6

7.5

194

1250

A01

ICPC

Pain general/multiple sites

1.6

7.5

183

1162

H34.2

ICD-10 Finland

Other retinal artery occlusions

5.7

7.5

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

4.3

7.5

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.6

7.5

203

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.0

7.5

435

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

7.5

506

3944

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.7

7.4

161

991

R52.9

ICD-10 Finland

Pain, unspecified

1.6

7.4

200

1304

PA2JT

NOMESCO Finland

Very extensive embolisation of arterio-venous malformation of the brain

+∞

7.3

43399

ICD-8 Finland

Cerebral thrombosis, Without mention of hypertension

+∞

7.3

I61.3

ICD-10 Finland

Intracerebral haemorrhage in brain stem

+∞

7.3

AAF15

NOMESCO Finland

Ventriculoatrial shunt

10.9

7.3

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.7

7.3

158

974

R47.1

ICD-10 Finland

Dysarthria and anarthria

4.9

7.3

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

3.5

7.3

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

7.2

363

2694

UJH02

NOMESCO Finland

Anoscopy

1.8

7.2

110

610

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

7.2

621

5009

I72.4

ICD-10 Finland

Aneurysm and dissection of artery of lower extremity

7.3

7.2

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

3.9

7.2

78551

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD

2.0

7.1

407

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

1.9

7.1

516

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

7.1

148

903

PA6CG

NOMESCO Finland

Extensive MRI examination of neck vasculature with high intensity magnet

6.6

7.1

N07BB01

ATC

disulfiram; oral

1.9

7.1

103

561

G43.8

ICD-10 Finland

Other migraine

3.0

7.1

128

G43.3

ICD-10 Finland

Complicated migraine

3.0

7.1

128

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.9

7.1

503

ZXH06

SPAT

2.2

7.1

315

J01FF01

ATC

clindamycin; systemic

1.3

7.0

672

5492

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

7.0

157

974

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.5

7.0

201

1331

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.6

7.0

168

1061

G91.1

ICD-10 Finland

Obstructive hydrocephalus

7.0

L01

ICPC

Neck symptom/complaint

1.4

7.0

325

2377

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

7.0

427

3276

GBB00

NOMESCO Finland

Tracheostomy

3.7

6.9

C10AA04

ATC

fluvastatin; oral

1.5

6.9

213

1430

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

2.8

6.9

147

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

6.9

522

4134

N29

ICPC

Neurological sympt/complt other

2.7

6.9

171

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

3.3

6.8

C01DA14

ATC

isosorbide mononitrate; oral

1.4

6.8

299

2162

X58

ICD-10 Finland

Exposure to other specified factors

1.4

6.8

304

2209

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

6.8

1030

8894

SPAT1307

SPAT

Psychosocial counselling and guidance

1.8

6.8

102

562

RS221

NOMESCO Finland

3.0

6.7

116

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.5

6.7

248

1733

K89

ICPC

Transient cerebral ischaemia

4.1

6.7

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

6.6

563

4527

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.8

6.6

146

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

3.0

6.6

118

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

6.6

200

1340

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

6.6

411

3163

WX402

NOMESCO Finland

General anaesthesia

1.4

6.6

403

3089

N89

ICPC

Migraine

2.4

6.5

227

A01AB09

ATC

miconazole; local oral

1.5

6.5

217

1489

S09.9

ICD-10 Finland

Unspecified injury of head

3.2

6.5

PA2CM

NOMESCO Finland

Extensive MRI examination of vessels in the head with 3 Tesla magnet

70.0

6.4

2132

FHL

Ventricular operators sunt

70.0

6.4

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

3.2

6.4

PA2DG

NOMESCO Finland

Very extensive MRI examination of vessels in the head with high intensity magnet

14.3

6.4

75310

ICD-8 Finland

Congenital anomalies of urinary system, Ren polycysticus bilateralis

14.3

6.4

P15

ICPC

Chronic alcohol abuse

2.2

6.4

284

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

6.4

129

782

N06AB06

ATC

sertraline; oral

1.5

6.3

242

1707

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

11.0

6.3

ZY010

SPAT

3.2

6.3

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

9.3

6.3

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

9.3

6.3

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.2

6.3

258

A11CC03

ATC

alfacalcidol; systemic

2.3

6.3

246

A04

ICPC

Weakness/tiredness general

1.4

6.3

274

1984

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

6.3

670

5549

2164

FHL

Crotigree

+∞

6.2

PA1AC

NOMESCO Finland

Aortocervical angiongraphy with X-ray

+∞

6.2

I67.5

ICD-10 Finland

Moyamoya disease

+∞

6.2

I61.4

ICD-10 Finland

Intracerebral haemorrhage in cerebellum

+∞

6.2

I67

ICD-10 Finland

Other cerebrovascular diseases

+∞

6.2

OAB47

SPAT

2.4

6.2

208

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.5

6.2

182

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

6.2

206

1408

C08DA01

ATC

verapamil; systemic

1.8

6.2

101

573

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

0.1

6.2

235

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

3.1

6.2

101

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

3.6

6.2

K92.1

ICD-10 Finland

Melaena

1.7

6.2

108

627

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

1.9

6.1

413

K59.09

ICD-10 Finland

Constipation, unspecified

1.6

6.1

132

816

N05CF02

ATC

zolpidem; oral

1.3

6.1

430

3366

T90.5

ICD-10 Finland

Sequelae of intracranial injury

2.9

6.1

113

SPF00

NOMESCO Finland

Repatation of teeth prosthesis

2.0

6.1

349

C07AG02

ATC

carvedilol; oral

1.6

6.1

135

840

EBA15

NOMESCO Finland

Extraction of large number of teeth

1.9

6.1

458

L04AA06

ATC

mycophenolic acid; systemic

2.4

6.1

197

S06.6

ICD-10 Finland

Traumatic subarachnoid haemorrhage

3.7

6.1

SPAT1312

SPAT

General health counselling

1.2

6.0

775

6552

G40.1

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

8.6

6.0

SPAT1234

SPAT

Support of social functional capacity

1.8

6.0

105

608

R60.0

ICD-10 Finland

Localized oedema

1.4

6.0

256

1844

K86

ICPC

Hypertension uncomplicated

1.4

6.0

284

2081

G40.00

ICD-10 Finland

Benign childhood epilepsy with centrotemporal EEG spikes

10.0

6.0

F80.1

ICD-10 Finland

Expressive language disorder

5.2

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

297

145

22.35

307.65

1.5

1.9

—

(3027801) Oxygen [Partial pressure] in Arterial blood

940

3068

3.86

244.58

6.9

7.5

kpa

14.5

12.4

15.29

902

2932

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

940

3069

3.85

244.45

6.9

7.5

kpa

5.1

0.31

904

2930

(3003396) Base excess in Arterial blood by calculation

936

3051

3.86

243.94

6.9

7.5

mmol/l

0.9

1.2

1.68

724

2376

(3018677) aPTT in Platelet poor plasma by Coagulation assay

954

3652

3.24

187.69

2.0

29.0

29.7

2.97

927

3542

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1541

8022

2.69

167.98

2.5

2.0

u/l

209.7

204.0

0.07

1478

7468

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

466

1359

3.82

137.37

6.5

9.8

mmol/l

24.1

24.4

1.49

449

1270

(3016502) Oxygen saturation in Arterial blood

706

2739

2.99

130.82

8.3

7.9

96.2

95.8

0.75

683

2641

(3002173) Hemoglobin [Mass/volume] in Arterial blood

669

2555

3.02

127.21

8.6

8.3

g/l

122.8

121.2

1.33

649

2451

(3014007) Fractional oxyhemoglobin in Arterial blood

511

1686

3.39

124.21

8.3

9.0

94.5

94.1

1.06

511

1679

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

501

1680

3.33

118.34

8.5

8.9

1.4

1.3

1.30

501

1670

(3013826) Glucose [Moles/volume] in Serum or Plasma

2342

16367

2.39

117.15

6.7

4.5

mmol/l

6.5

6.7

3.79

2240

15311

(3019060) Gas panel - Arterial blood

509

1803

3.15

109.27

6.6

5.1

—

(3020891) Body temperature

373

1093

3.71

108.21

6.3

4.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

481

1719

3.10

101.29

10.5

7.1

mmol/l

24.8

24.7

0.49

455

1592

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1930

12933

2.14

99.73

7.8

5.9

mmol/l

1.2

26.68

1808

11673

(3014576) Chloride [Moles/volume] in Serum or Plasma

745

3390

2.53

98.52

6.9

6.8

mmol/l

104.8

104.3

1.96

735

3318

(3032080) INR in Blood by Coagulation assay

1721

11086

2.12

98.10

9.4

8.5

inr

1.2

0.03

448

3163

(3033658) Prothrombin time (PT) actual/Normal

1217

6931

2.18

94.82

4.7

3.7

95.4

92.1

4.64

1175

6745

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

226

539

4.42

86.68

1.8

1.3

e6/l

34.2

27.9

0.17

186

415

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

226

540

4.41

86.47

1.9

1.3

e6/l

5612.7

948.5

1.25

194

441

(3044290) Cell count panel - Cerebral spinal fluid

212

491

4.54

84.37

1.8

1.3

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1998

14278

1.97

78.20

8.6

6.7

mmol/l

1.2

21.51

1780

12033

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

235

623

3.98

78.14

1.6

1.3

mg/l

556.1

524.6

0.35

225

591

(3044640) Blood type and Crossmatch panel - Blood

1398

8876

1.98

77.21

2.6

2.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

726

3663

2.25

73.69

8.4

6.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1119

6774

1.97

69.23

2.5

2.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

510

2265

2.47

69.03

2.7

2.3

ug/l

6.5

6.8

0.07

450

2000

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1547

10619

1.84

63.53

4.2

3.4

ng/l

32.6

96.7

0.82

1143

7151

(40761535) Cells panel - Urine sediment

505

2331

2.37

62.34

4.3

3.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1067

6542

1.92

62.26

4.6

3.6

—

(3036489) Thrombin time

255

846

3.18

59.94

2.0

1.9

20.3

21.6

3.72

230

729

(3020779) Urea [Moles/volume] in Serum or Plasma

502

2356

2.33

59.47

7.0

7.4

mmol/l

8.4

9.7

4.09

475

2248

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

194

554

3.65

57.77

1.5

1.2

mmol/l

3.6

3.7

0.64

181

521

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

113

215

5.40

56.55

2.6

1.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1801

13238

1.77

56.28

4.4

3.9

—

(3000991) Gas panel - Venous blood

460

2155

2.31

54.44

8.3

8.4

—

(3019150) Specific gravity of Urine by Refractometry

975

6028

1.87

54.02

5.1

4.0

kg/l

1.0

0.13

884

(3014111) Lactate [Moles/volume] in Serum or Plasma

482

2323

2.25

53.25

6.9

7.0

mmol/l

1.3

0.93

464

2246

(3012095) Magnesium [Moles/volume] in Serum or Plasma

754

4498

1.87

45.63

3.3

3.4

mmol/l

0.8

0.61

701

4192

(3015736) pH of Urine

1477

10699

1.67

45.02

4.4

3.4

—

5.6

—

(3029937) Albumin [Presence] in Urine by Test strip

1096

7401

1.71

43.04

5.0

4.0

estimate

0.0

1.08

246

2495

(3023410) Appearance of Cerebral spinal fluid

103

235

4.49

41.65

2.1

1.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

613

3537

1.89

40.65

7.0

5.8

mmol/l

1.0

0.12

567

3275

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

447

2339

2.05

39.28

2.6

2.7

ml/min/173m2

64.0

66.2

0.47

164

928

(3024561) Albumin [Mass/volume] in Serum or Plasma

1619

12311

1.60

38.55

5.2

4.8

g/l

35.3

35.6

1.89

1533

11434

(3016018) Differential panel - Cerebral spinal fluid

100

248

4.12

36.30

2.2

1.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

569

3399

1.81

33.17

25.2

22.4

inr

1.4

1.3

0.48

506

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

177

4.55

32.70

1.8

1.3

mmol/l

2.3

2.2

0.27

166

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

112

5.53

31.76

2.7

1.3

—

(3023368) Bacteria identified in Blood by Culture

1038

7353

1.59

31.66

4.5

4.3

—

(3035350) Ketones [Presence] in Urine by Test strip

1731

13812

1.52

30.39

4.6

3.6

estimate

0.0

0.00

262

2500

(3031040) Bacteria [#/volume] in Urine by Automated count

2195

18500

1.53

29.13

5.4

4.4

e6/l

910.7

1816.8

0.72

252

(3009261) Glucose [Presence] in Urine by Test strip

1737

14016

1.49

27.91

4.6

3.7

estimate

0.0

0.27

254

2484

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1380

10633

1.50

27.80

4.8

3.8

—

(3021601) Nitrite [Presence] in Urine by Test strip

1717

13864

1.48

27.22

5.8

4.9

estimate

0.0

0.80

257

2546

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

251

1210

2.16

27.06

2.9

2.6

0.7

0.21

244

1154

(4034850)

210

942

2.31

26.97

11.0

9.6

—

(3026008) Bacteria identified in Urine by Culture

1134

8478

1.51

25.97

3.6

3.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

350

1976

1.86

24.07

3.6

2.9

kpa

4.6

0.23

342

1914

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

191

864

2.28

24.05

2.2

2.3

ug/l

600.7

810.0

0.28

180

807

(3021447) Carbon dioxide [Partial pressure] in Venous blood

405

2408

1.77

23.47

4.5

3.6

kpa

5.8

0.07

396

2335

(3002032) Base excess in Venous blood by calculation

401

2397

1.76

22.78

4.5

3.7

mmol/l

1.7

2.1

1.24

340

1958

(3019309) Folate [Moles/volume] in Red Blood Cells

725

5039

1.56

22.78

1.8

1.7

nmol/l

1272.0

1173.2

2.16

593

3804

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1180

9072

1.46

22.75

2.9

2.5

u/l

57.7

58.1

0.10

1096

8348

(3018418) pH of Serum or Plasma

1116

8506

1.47

22.43

4.9

4.1

7.4

0.51

185

1615

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1804

15023

1.43

22.43

6.1

6.2

umol/l

10.4

11.1

1.97

1730

14230

(3004119) Hemoglobin [Mass/volume] in Venous blood

295

1638

1.88

21.31

3.4

3.1

g/l

127.2

129.0

0.62

289

1590

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

166

749

2.28

21.03

2.3

2.1

96.4

90.5

2.73

156

699

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

112

4.52

20.78

1.7

1.3

48.5

71.0

1.12

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

270

1476

1.90

20.45

9.9

10.5

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1047

8001

1.45

20.31

2.7

2.9

ng/l

1092.4

1261.7

0.78

909

6816

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

172

806

2.19

19.89

3.4

3.0

u/ml

0.3

0.17

102

450

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

669

4704

1.53

19.59

3.0

2.6

e6/l

1.5

1.1

0.59

413

2687

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

151

685

2.26

18.90

2.6

2.3

177.0

191.2

1.25

145

649

(3027273) Bicarbonate [Moles/volume] in Venous blood

236

1272

1.92

18.64

3.7

3.2

mmol/l

25.3

25.5

0.55

231

1224

(1761868) Lipid panel - Serum or Plasma

776

10263

0.68

18.48

3.0

2.9

—

(3039000) Anion gap in Blood

141

632

2.28

18.17

9.3

8.2

mmol/l

10.5

11.2

2.44

125

561

(3018572) Chloride [Moles/volume] in Blood

141

633

2.28

18.10

9.3

8.2

mmol/l

106.1

105.2

1.54

125

562

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

265

1501

1.83

17.93

1.6

1.4

—

(3044889) 12 lead EKG panel

2319

20617

1.40

17.25

4.3

3.7

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

4.91

17.08

3.2

2.6

umol/l

28.5

28.4

0.02

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

4.63

16.79

2.3

2.1

umol/l

57.2

56.2

0.06

(3023183) Ammonium ion [Moles/volume] in Plasma

119

514

2.36

16.72

2.8

3.0

umol/l

33.4

37.0

0.68

105

435

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3036

28483

1.63

16.62

18.9

13.7

mg/l

23.5

23.3

0.09

2585

22456

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

612

4368

1.49

16.38

2.0

1.8

—

(36304419) Bacteria [Presence] in Urine

960

7450

1.40

16.36

3.6

2.9

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

452

3023

1.57

16.36

1.8

1.7

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

825

6235

1.43

16.35

1.9

1.7

mg/l

1.1

1.2

0.46

657

4796

(3036481) Cortisol [Moles/volume] in Serum or Plasma

395

2565

1.61

16.19

2.6

2.2

nmol/l

373.2

368.9

0.19

370

2355

(3030467) Casts [#/volume] in Urine by Automated count

980

7658

1.39

15.96

3.6

3.0

e6/l

0.4

0.11

765

5746

(3003181) Sodium [Moles/volume] in Urine

111

477

2.37

15.79

1.4

mmol/l

71.2

63.3

0.92

384

(3013707) Erythrocyte sedimentation rate by Westergren method

2378

21364

1.38

15.65

4.5

4.1

mm/h

13.2

12.3

2.26

2250

19726

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

4.64

15.16

1.6

1.1

25.1

8.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

444

3019

1.54

14.86

1.8

1.7

—

(3007853) Bacteria identified in Skin by Aerobe culture

459

3148

1.53

14.76

1.8

1.7

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

205

1139

1.85

14.75

7.6

5.8

1.7

1.6

0.51

188

1062

(3007930) Methemoglobin/Hemoglobin.total in Blood

204

1133

1.85

14.69

7.6

5.8

1.0

0.9

1.36

188

1056

(3019550) Sodium [Moles/volume] in Serum or Plasma

3131

29769

1.68

14.22

22.7

15.5

mmol/l

139.5

139.7

7.62

3093

29045

(3015377) Calcium [Moles/volume] in Serum or Plasma

1205

9889

1.34

13.94

2.9

3.5

mmol/l

2.4

0.35

1060

8606

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

141

3.44

13.83

1.2

1.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

876

6862

1.37

13.67

2.4

2.2

mg/l

3.2

3.0

1.75

772

5849

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

702

5310

1.41

13.50

2.5

3.1

mmol/l

2.4

2.5

1.25

620

4662

(3000850) Epithelial cells [#/volume] in Urine

757

5807

1.39

13.38

3.0

2.5

e6/l

5.2

5.9

0.78

669

5067

(3023103) Potassium [Moles/volume] in Serum or Plasma

3133

29858

1.65

13.26

22.3

15.6

mmol/l

4.0

0.08

3092

29082

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2463

22466

1.35

13.22

8.2

7.6

u/l

77.2

78.0

0.35

2361

21133

(3047181) Lactate [Moles/volume] in Blood

161

871

1.89

12.61

9.1

7.0

mmol/l

1.2

1.3

0.61

138

760

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

131

3.39

12.45

1.2

1.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

340

2273

1.55

12.20

1.9

2.8

g/l

66.3

66.5

0.20

312

2065

(3042733) HLA Ab [Presence] in Serum

4.08

11.84

5.1

5.3

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

194

2.87

11.74

1.7

1.3

promille

1.4

1.2

0.36

150

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

359

2.34

11.73

1.4

1.2

u/ml

4.6

2.4

0.57

116

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

352

2.33

11.34

1.4

1.2

u/ml

5.9

4.1

0.56

140

(3003338) MCHC [Mass/volume]

2586

23978

1.33

10.95

25.1

17.7

g/l

332.1

331.9

0.50

2570

23825

(3009466) Valproate [Moles/volume] in Serum or Plasma

339

2.33

10.93

3.6

5.5

umol/l

357.0

363.4

0.13

302

(3019198) Lymphocytes [#/volume] in Blood

1647

14420

1.28

10.86

6.3

5.9

e9/l

1.8

1.9

2.04

1465

12674

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

684

5318

1.36

10.85

4.3

3.6

ng/l

422.7

585.0

0.32

536

4102

(3037467) Urinalysis macro (dipstick) panel - Urine

2145

19423

1.28

10.69

5.2

4.3

—

(4010399)

311

2100

1.53

10.65

1.5

1.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

805

6448

1.33

10.40

1.5

nmol/l

19.6

20.9

1.69

698

5474

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.94

10.29

1.2

—

(3024471) HLA-A [Type]

3.72

10.13

1.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

118

3.25

10.12

30.1

26.7

ug/l

112.2

0.00

100

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

141

787

1.83

10.07

2.0

1.7

g/l

0.2

0.02

135

739

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

260

2.45

9.93

2.8

2.6

—

(4306422)

354

2.23

9.91

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

335

2.27

9.90

1.1

124.3

117.5

1.18

296

(3006315) Basophils [#/volume] in Blood

1603

14089

1.26

9.87

6.3

5.8

e9/l

0.0

0.16

1418

12134

(3024932) HLA-DR beta [Type]

3.68

9.69

1.0

1.1

—

(3001604) Monocytes [#/volume] in Blood

1594

14026

1.26

9.62

6.3

5.8

e9/l

0.6

0.22

1411

12080

(40761511) CBC panel - Blood by Automated count

3097

29718

1.49

9.47

18.0

12.9

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1345

11625

1.26

9.40

2.1

2.0

pmol/l

95.4

96.7

0.43

719

5815

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

143

821

1.77

9.32

2.0

1.6

g/l

1.2

0.07

136

777

(3017143) Hepatitis C virus Ab [Presence] in Serum

381

2756

1.43

9.21

1.9

1.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

420

3093

1.41

9.18

2.0

1.7

1.4

4.68

374

2731

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

462

2.02

9.04

1.6

1.4

u/ml

121.8

120.2

0.05

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

360

2.14

8.73

1.6

1.3

nmol/l

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

287

1987

1.49

8.72

2.4

au/ml

23.2

0.00

109

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

163

2.72

8.66

1.0

1.1

nmol/l

4.1

7.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1829

16473

1.24

8.53

8.9

9.3

e9/l

4.2

4.0

3.27

1636

14384

(3051593) INR in Capillary blood by Coagulation assay

3.81

8.50

9.5

16.9

—

(3002582) Erythrocytes [#/volume] in Urine

990

8330

1.27

8.48

3.8

3.1

e6/l

126.6

75.1

0.26

767

6382

(3018095) Leukocytes [#/volume] in Urine

1147

9820

1.25

8.47

4.4

3.6

e6/l

72.1

102.2

1.24

836

6902

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

113

626

1.83

8.33

1.3

1.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

2430

25805

0.79

7.99

20.4

14.7

39.2

39.7

1.83

1644

18285

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

308

2203

1.44

7.91

5.5

3.7

ng/l

96.1

88.0

0.71

272

1889

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

261

1810

1.48

7.87

1.3

au/ml

27.2

46.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2389

22245

1.25

7.85

4.5

4.1

pmol/l

15.0

14.8

3.57

2227

20252

(46235355) HIV 1 and 2 tests - Meaningful Use set

477

3677

1.35

7.82

2.0

1.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

234

2.33

7.72

1.1

1.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

286

2.19

7.66

1.0

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

339

2.09

7.64

1.2

1.4

pmol/l

372.2

293.4

0.71

268

(3013115) Eosinophils [#/volume] in Blood

1629

14595

1.22

7.62

6.5

6.0

e9/l

0.2

0.07

1458

12780

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

406

1.97

7.35

1.5

1.3

nmol/l

0.6

0.03

390

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

413

1.96

7.35

1.6

1.3

nmol/l

0.2

0.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

520

1.85

7.32

1.6

1.4

—

(3011985) Renin [Units/volume] in Plasma

361

2.02

7.18

1.3

1.5

mu/l

74.8

36.9

1.20

322

(4268621)

242

2.25

7.17

2.6

2.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1334

11765

1.22

7.14

3.2

2.8

ug/l

130.4

129.0

0.06

1252

10868

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

184

1211

1.55

7.13

5.4

4.0

mmol/l

23.7

24.3

1.69

165

1091

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

368

1.98

6.83

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

236

2.22

6.72

1.3

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

165

1079

1.56

6.60

2.0

ug/l

3.5

2.0

0.64

143

973

(3034426) Prothrombin time (PT)

3.18

6.56

1.3

1.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

274

1995

1.41

6.39

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

125

773

1.64

6.32

1.2

1.3

—

(3042936) Bacteria identified in Isolate by Culture

491

3916

1.30

6.27

2.0

—

(3009508) Creatinine [Moles/volume] in Urine

1027

8912

1.22

6.26

3.2

3.1

mmol/l

7.2

7.4

0.44

899

7502

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

378

1.90

6.02

1.6

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

261

2.09

6.00

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

302

2.00

5.99

1.5

1.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

141

911

1.57

5.98

3.2

2.7

—

(3022948) Iron [Moles/volume] in Serum or Plasma

533

4327

1.28

5.91

3.0

2.5

umol/l

12.9

13.2

0.40

502

4015

(3027945) Reticulocytes/100 erythrocytes in Blood

380

2953

1.32

5.87

2.2

2.5

1.9

1.8

1.02

338

2622

(3037522) Nuclear Ab [Titer] in Serum

478

3832

1.29

5.86

1.3

titre

497.0

514.4

0.06

802

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.30

5.85

1.0

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

246

2.09

5.72

1.5

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

246

2.09

5.72

1.5

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

246

2.09

5.72

1.5

1.7

—

(3023520) Reticulocytes [#/volume] in Blood

295

2218

1.36

5.68

2.2

2.6

e9/l

73.6

69.7

0.92

230

1683

(3026782) Osmolality of Urine

642

5352

1.25

5.66

3.2

2.7

mosm/kgh2o

508.5

541.6

3.67

550

4550

(3024928) Oxygen saturation in Venous blood

564

1.70

5.65

2.9

—

(3008295) Osmolality of Serum or Plasma

295

1.98

5.64

1.5

1.4

mosm/kgh2o

272.1

276.4

0.60

229

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.11

5.61

1.0

1.1

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

461

3702

1.28

5.57

3.2

2.5

22.6

23.1

0.26

394

3153

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

553

1.70

5.51

7.2

5.6

iu/ml

636.0

288.5

0.51

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

173

2.27

5.39

1.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

135

886

1.55

5.38

1.7

1.6

titre

104.0

324.2

—

(3006653) Thiamine [Moles/volume] in Blood

149

2.36

5.31

1.3

nmol/l

137.8

135.4

0.08

149

(3052851) Hemolysis interference index of Serum or Plasma

125

809

1.57

5.30

3.3

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3142

30598

1.37

5.28

21.8

16.0

umol/l

77.1

75.8

0.98

3142

30586

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

175

2.24

5.25

1.2

—

(3016038) Potassium [Moles/volume] in Urine

175

2.24

5.25

1.2

mmol/l

26.8

35.0

2.54

150

(3014765) Yersinia sp identified in Stool by Organism specific culture

125

811

1.56

5.25

1.2

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2754

26396

1.23

5.20

5.4

4.8

mu/l

1.9

2.2

1.80

2592

24107

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1989

18514

1.18

5.19

3.8

3.1

u/l

55.3

49.0

1.71

1867

17111

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

442

1.76

5.18

1.2

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

151

2.33

5.16

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

177

2.22

5.12

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

395

3145

1.29

5.10

1.8

1.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

125

817

1.55

5.09

1.2

—

(3025941) Bacteria identified in Stool by Culture

215

1564

1.40

5.09

1.4

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

110

2.56

5.04

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.91

5.03

1.0

1.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

253

1897

1.36

4.98

1.9

2.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

111

713

1.58

4.89

3.9

3.1

mg/l

1.5

0.08

101

646

(3003327) Ova and parasites identified in Stool by Light microscopy

128

852

1.52

4.82

1.7

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.64

4.81

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

386

3088

1.28

4.80

3.5

4.2

u/l

232.2

246.1

1.23

369

2920

(3015171) Extractable nuclear Ab [Units/volume] in Serum

162

1132

1.45

4.80

1.2

1.3

u/ml

1.3

1.1

0.09

101

(3035637) Corticotropin [Mass/volume] in Plasma

349

1.82

4.80

1.8

1.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

122

806

1.53

4.76

1.2

1.1

—

(3000330) Specific gravity of Urine by Test strip

1447

0.63

4.75

4.7

3.5

—

(40758558) Short blood count panel - Blood

838

7293

1.20

4.75

6.7

6.8

—

(3003694) ABO and Rh group [Type] in Blood

854

7449

1.20

4.71

1.3

1.4

—

(3009343) pH of Capillary blood

221

1637

1.37

4.71

4.6

3.5

7.4

0.08

202

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

280

1.91

4.68

1.5

1.8

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

191

2.11

4.66

1.1

mg/l

42.3

42.0

0.01

160

(3012516) Albumin [Mass/volume] in Urine

968

8551

1.18

4.61

3.3

3.2

mg/l

425.5

334.9

0.25

634

5232

(3000494) Fungus identified in Specimen by Culture

419

3403

1.26

4.61

1.6

1.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.76

4.61

1.0

1.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

223

1664

1.36

4.55

4.6

3.5

kpa

5.2

0.03

209

1547

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

110

2.47

4.54

2.7

2.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

271

2084

1.33

4.53

2.3

2.8

g/l

9.9

10.3

0.74

238

1901

(3004789) Transferrin [Mass/volume] in Serum or Plasma

481

3978

1.24

4.52

3.1

2.5

g/l

2.3

0.10

453

3688

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1330

12077

1.17

4.49

2.3

nmol/l

77.9

78.9

0.59

1199

10839

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

149

1039

1.45

4.49

5.2

3.7

mmol/l

24.9

25.1

0.32

138

970

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

177

2421

0.72

4.48

1.8

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.60

4.48

4.8

5.2

—

(40768797) Stomach Pathology biopsy report

498

4143

1.24

4.43

1.3

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

2.56

4.38

3.1

2.3

u/ml

1590.3

31483.8

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2776

26746

1.21

4.32

5.9

5.7

mmol/mol

39.3

39.8

2.68

2619

24691

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

184

2.08

4.30

1.0

mg/l

341.6

289.3

0.20

160

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.79

4.28

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

712

6159

1.20

4.26

1.6

1.7

pmol/l

9531946.4

37539438.7

1.62

619

5128

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

126

2.31

4.26

1.4

1.2

—

(3010421) pH of Blood

109

722

1.53

4.24

3.3

4.3

7.4

0.03

600

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.85

4.22

1.1

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.85

4.22

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

291

1.83

4.20

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

140

2.23

4.17

1.2

1.1

ratio

1.1

1.0

1.56

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

516

4339

1.22

4.14

3.4

2.8

e6/l

2.6

2.8

0.24

268

2337

(3022313) Gas panel - Capillary blood

166

1200

1.40

4.13

4.9

3.6

—

(40768446) Kidney Pathology biopsy report

103

2.44

4.13

2.6

1.6

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

103

2.44

4.13

1.8

2.6

umol/l

127.7

188.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

497

1.62

4.10

1.4

1.2

—

(3051651) Icteric interference index of Serum or Plasma

161

2.12

4.09

2.7

3.9

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

209

1572

1.35

4.08

4.6

3.5

mmol/l

1.6

2.0

0.72

163

1194

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.09

4.08

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

293

2313

1.29

4.07

2.8

ng/l

180.1

184.2

0.07

268

2103

(3020682) Albumin/Creatinine [Ratio] in Urine

1007

9003

1.17

4.06

3.8

3.9

mg/mmol

9.8

7.7

0.63

646

5562

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

252

1.88

4.02

1.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

334

2689

1.27

3.97

2.2

g/l

0.2

0.28

308

2515

(3028707) Methadone [Presence] in Urine by Screen method

254

1.86

3.93

2.1

2.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

102

678

1.52

3.93

1.9

1.6

mu/l

306.2

304.7

0.01

621

(4027681)

144

2.16

3.92

1.3

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

171

2.06

3.90

1.4

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.64

3.89

1.3

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

263

1.84

3.85

2.5

2.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

166

2.06

3.80

1.4

1.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

134

948

1.43

3.79

1.6

1.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

462

1.62

3.75

1.5

1.2

u/ml

300.7

280.4

0.23

281

(3028679) Herpes simplex virus Ab [Presence] in Serum

121

2.24

3.73

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

4.01

3.69

1.5

1.2

—

(3011288) Drugs identified in Urine by Screen method

372

1.68

3.67

2.7

2.4

—

(3014271) Vancomycin [Susceptibility]

116

2.25

3.64

3.2

2.7

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

443

1.62

3.62

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

170

2.01

3.58

1.5

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

161

1194

1.37

3.48

1.9

u/l

37.6

39.4

0.45

139

1067

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

125

2.17

3.47

2.0

1.7

nmol/l

5.1

9.0

0.40

106

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

402

1.63

3.45

1.3

1.5

—

(3016879) Cocaine [Presence] in Urine

529

1.54

3.43

2.1

1.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

846

7549

1.16

3.41

3.0

2.6

umol/l

2280.1

4911.8

1.78

753

6544

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

167

1.99

3.38

1.5

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

114

2.20

3.34

1.5

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

114

2.20

3.34

1.5

2.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.45

3.33

1.1

—

(3002385) Erythrocyte distribution width [Ratio]

2261

23600

0.87

3.33

22.0

16.8

13.8

13.7

2.42

2231

23081

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

533

1.53

3.32

1.4

1.7

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

115

2.18

3.28

1.6

2.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

514

1.53

3.19

1.3

1.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.34

3.19

1.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

703

6215

1.17

3.19

4.5

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

207

1.85

3.16

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

207

1.85

3.16

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

104

730

1.44

3.13

1.8

1.7

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

208

1.84

3.12

1.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

199

1554

1.30

3.06

1.9

1.6

—

(21494755) Public health laboratory ask at order entry panel

187

2390

0.77

3.05

1.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

210

1.82

3.04

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

210

1.82

3.04

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

210

1.82

3.04

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

126

2.07

3.02

1.6

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

126

2.07

3.02

1.6

1.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

121

879

1.39

3.01

1.4

1.9

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

236

1888

1.27

3.01

1.8

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

172

1322

1.32

2.98

1.3

1.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.15

2.93

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

100

707

1.43

2.92

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

437

1.54

2.90

2.0

1.5

—

(3027008) Opiates [Presence] in Urine

575

1.47

2.90

2.0

1.7

—

(3023420) DNA double strand Ab [Units/volume] in Serum

296

1.67

2.90

2.5

1.3

iu/ml

45.4

21.9

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

2.22

2.89

1.2

g/l

0.3

0.38

(3006184) Hemoglobin [Mass/volume] in Capillary blood

592

1.46

2.89

1.9

2.2

g/l

127.3

128.6

0.18

426

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1015

9267

1.14

2.89

3.7

3.2

u/l

31.6

35.5

1.05

961

8801

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

115

2.09

2.88

1.0

1.2

—

(4198724)

2.51

2.87

1.7

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2891

28176

1.18

2.86

5.1

4.6

mmol/l

5.9

0.34

2700

25689

(3045716) Anion gap in Serum or Plasma

129

2.02

2.85

2.5

2.6

mmol/l

9.0

0.00

100

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

399

1.56

2.85

1.8

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

212

1686

1.27

2.85

1.8

1.7

—

(3014051) Protein [Presence] in Urine by Test strip

671

0.59

2.83

2.8

2.3

—

(3002256) Pathology report gross observation

328

3901

0.82

2.83

1.2

1.3

—

(3000764) Benzodiazepines [Presence] in Urine

572

1.46

2.78

2.1

1.7

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

145

1.94

2.74

1.0

1.1

u/l

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

5.01

2.72

3.9

5.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

127

948

1.35

2.71

2.0

1.7

—

(3028300) Cannabinoids [Presence] in Urine

576

1.45

2.70

2.1

1.7

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.13

2.64

1.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

706

0.62

2.62

5.8

4.5

—

(3049717) Cytology report of Urine Cyto stain

135

1024

1.33

2.60

2.4

2.5

—

(3027944) Amphetamines [Presence] in Urine

564

1.45

2.60

2.0

1.6

—

(3040151) Glucose [Moles/volume] in Capillary blood

290

1.63

2.60

3.8

4.7

mmol/l

6.8

7.2

0.37

243

(3020123) Porphyrins [Interpretation] in Serum or Plasma

4.67

2.59

1.0

—

(44806071)

3.61

2.57

1.2

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

500

1.47

2.55

1.9

u/l

6774.3

3346.0

0.46

182

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

121

1.99

2.55

1.1

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

121

1.99

2.55

1.1

1.4

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

331

1.58

2.54

2.2

1.9

ug/l

30.4

24.9

0.12

325

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

676

1.40

2.54

1.4

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.04

2.52

7.8

11.9

mmol/l

6.3

5.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

155

1206

1.30

2.51

1.8

1.7

g/l

1.7

1.6

0.71

139

1046

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

143

1.90

2.50

1.7

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

143

1.90

2.50

1.7

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

143

1.90

2.50

1.7

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

143

1.90

2.50

1.7

1.9

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

704

1.39

2.49

1.4

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

102

2.07

2.47

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.09

2.42

1.1

miu/ml

1264.4

1612.4

0.66

(3011648) Oxygen content in Venous blood

228

1.67

2.36

2.9

2.0

10.3

11.1

0.51

228

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.64

2.36

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

399

4584

0.85

2.34

2.8

3.0

ug/l

0.8

0.17

261

3052

(3023419) Bacteria identified in Sputum by Culture

363

1.52

2.32

2.1

2.6

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

112

1.97

2.30

2.2

2.3

—

(1616796) Gas panel - Central venous blood

589

1.40

2.26

3.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

398

1.49

2.26

1.2

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

700

1.37

2.25

1.5

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

685

1.37

2.22

1.4

1.7

—

(40767503) Oxygen content in Capillary blood by calculation

583

1.40

2.22

2.5

16.0

16.1

0.05

292

(3019832) Treponema pallidum Ab [Presence] in Serum

178

1434

1.25

2.21

1.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

400

1.48

2.21

1.3

1.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.51

2.18

1.1

1.0

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

111

844

1.33

2.16

1.5

2.2

g/l

38.1

37.9

0.16

728

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

220

1820

1.22

2.15

3.3

pmol/l

4.5

0.00

192

1612

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

502

1.42

2.15

1.5

1.8

—

(3012501) Base excess in Blood by calculation

604

1.38

2.14

3.2

4.4

mmol/l

2.4

2.8

0.83

433

(3024980) IgG subclass 4 [Mass/volume] in Serum

428

1.46

2.14

1.5

g/l

0.7

0.02

312

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

120

925

1.31

2.13

1.6

2.4

g/l

0.5

1.0

1.23

101

804

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

125

1597

0.77

2.11

1.4

1.5

—

(40768793) Breast Pathology biopsy report

787

0.68

2.11

1.2

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

555

1.40

2.10

1.6

1.3

u/l

11.0

12.2

0.29

452

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.71

2.10

1.6

2.2

umol/l

22.6

19.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

744

1.34

2.09

1.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

3.21

2.09

1.4

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

455

1.44

2.09

1.3

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

228

1900

1.21

2.09

1.2

iu/ml

120.4

152.1

0.62

703

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

130

1019

1.29

2.04

1.8

2.4

g/l

3.1

0.12

104

797

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

748

1.33

2.03

1.5

2.3

g/l

0.0

0.00

693

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.40

2.02

1.1

1.2

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.40

2.02

1.1

1.2

103.1

100.4

0.16

(3039443) Prostate specific Ag panel - Serum or Plasma

491

0.61

2.02

1.6

1.7

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

352

3063

1.17

1.98

1.5

1.6

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.15

1.98

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

492

4388

1.14

1.98

1.5

1.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.97

1.93

1.0

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

665

6053

1.12

1.93

1.2

u/ml

1.0

1.8

2.74

206

1594

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.12

1.92

5.4

8.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

198

1645

1.22

1.89

1.7

1.9

g/l

1.3

1.4

0.15

178

1501

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

510

1.38

1.84

1.4

1.3

—

292.3

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

286

1.51

1.82

1.4

g/l

0.4

0.12

194

(3028192) IgG subclass 2 [Mass/volume] in Serum

286

1.51

1.82

1.4

g/l

2.7

2.8

0.26

195

(3027135) IgG subclass 1 [Mass/volume] in Serum

286

1.51

1.82

1.4

g/l

6.1

6.8

0.60

193

(4062490)

286

1.51

1.82

1.4

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

108

1.86

1.81

1.0

1.1

ng/l

—

476.4

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.06

1.80

1.5

ug/l

0.5

0.4

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.58

1.80

1.1

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

126

1003

1.27

1.79

1.5

2.4

g/l

9.7

10.2

0.62

105

853

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

595

0.67

1.78

4.1

3.6

u/ml

17.8

33.4

3.47

580

(3001019) Free T4 and TSH panel - Serum or Plasma

116

1460

0.79

1.78

2.1

1.8

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

212

1786

1.20

1.77

1.6

1.4

—

(3022621) pH of Urine by Test strip

152

1854

0.81

1.77

3.0

—

(3000285) Sodium [Moles/volume] in Blood

2.44

1.75

1.4

1.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2802

27449

1.12

1.75

4.5

4.0

mmol/l

1.3

2.27

2600

25006

(3002621) Streptococcal DNAse B [Units/volume] in Serum

3.34

1.74

1.0

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

1.98

1.74

1.5

2.4

137.2

158.6

0.40

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.50

1.74

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

508

1.37

1.72

3.6

2.9

nmol/l

0.9

0.8

0.39

386

(3042517) Benzodiazepines panel - Urine

3.85

1.71

2.2

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

743

1.30

1.71

1.5

2.3

g/l

0.0

0.00

692

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

141

1.71

1.68

3.0

2.4

u/ml

2926.3

1211.1

0.31

141

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

375

1.42

1.67

1.6

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

202

1707

1.19

1.65

2.5

2.2

nmol/l

13.0

12.8

0.11

180

1506

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2968

29198

1.13

1.63

5.6

5.0

mmol/l

2.6

2.8

23.21

2780

26830

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

102

803

1.28

1.61

1.6

2.3

g/l

0.0

1.56

743

(44806118)

336

1.43

1.61

1.4

—

(44790048)

336

1.43

1.61

1.4

—

(44790049)

336

1.43

1.61

1.4

—

(44790047)

336

1.43

1.61

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.15

1.61

1.0

1.2

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

113

1.77

1.60

1.8

2.1

106.8

150.7

3.47

105

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

2.07

1.59

5.3

6.9

71.5

74.6

0.18

(3024522) Salmonella sp identified in Specimen by Organism specific culture

379

1.40

1.59

1.6

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

304

2668

1.15

1.57

3.0

2.4

u/l

38.1

57.1

0.51

272

2286

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

674

1.30

1.56

1.4

1.3

miu/ml

155.9

198.7

0.73

302

(40768800) Prostate Pathology biopsy report

529

0.68

1.55

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

536

1.33

1.53

4.0

2.9

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

382

1.39

1.53

1.6

1.4

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

3.34

1.52

1.0

1.1

—

(3028433) Virus identified in Specimen by Culture

1.83

1.51

1.2

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

608

0.70

1.51

3.2

3.6

mg/l

32.5

25.1

0.39

363

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

107

856

1.26

1.50

1.6

iu/ml

0.1

7.5

0.52

168

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

183

1548

1.19

1.50

2.3

2.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.86

1.50

1.2

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

490

0.67

1.50

1.3

1.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

132

1082

1.23

1.50

1.8

2.4

g/l

3.7

3.8

0.18

103

777

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

132

1082

1.23

1.50

1.8

2.4

—

(3045414) Leukocytes [Presence] in Urine

108

1338

0.80

1.49

2.0

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

759

1.27

1.49

2.0

mg/l

11.0

11.4

0.18

699

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

384

1.39

1.49

1.0

1.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

132

1083

1.23

1.48

1.8

2.4

g/l

7.3

7.4

0.24

105

821

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.00

1.48

5.8

8.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

202

1.54

1.48

1.0

ng/l

545.9

751.8

1.72

131

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.81

1.47

3.0

2.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.37

1.45

1.2

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

102

1.77

1.44

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

360

3218

1.13

1.44

3.7

2.7

umol/l

7.4

7.7

0.10

309

2815

(3027570) Oxalate [Moles/time] in 24 hour Urine

3.13

1.44

1.6

1.5

umol/24h

298.8

348.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.73

1.43

1.2

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.31

1.43

1.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.31

1.43

2.6

1.3

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.31

1.43

1.1

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

204

1.52

1.43

1.0

ng/l

56.6

44.8

0.63

133

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

289

0.59

1.40

1.3

1.5

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

1.77

1.38

1.3

1.4

umol/l

2.6

3.6

1.10

(3043238) Trisomy 21 risk [Likelihood] in Fetus

237

0.55

1.38

1.2

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

280

1.43

1.38

2.3

4.4

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

150

1.60

1.37

2.1

1.5

ug/l

10.5

8.0

0.35

127

(40768795) Lymph node Pathology biopsy report

311

0.61

1.36

1.3

1.2

—

(3017509) Phencyclidine [Presence] in Urine

2.94

1.36

1.0

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

370

3327

1.13

1.36

2.0

2.3

ug/g

151.7

139.1

0.23

293

2613

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

248

1.46

1.35

1.2

1.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

273

1.43

1.35

1.3

e6/l

20121.8

49984.7

0.63

189

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

159

1.58

1.34

1.2

1.1

iu/ml

4.2

10.3

—

(3017732) Neutrophils [#/volume] in Blood

233

2033

1.16

1.34

3.0

3.1

e9/l

4.2

4.0

0.39

175

1595

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

134

1115

1.21

1.34

2.4

1.9

—

(3051611) Lipemic interference index of Serum or Plasma

282

1.42

1.33

2.9

3.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

136

1.62

1.32

1.5

2.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

110

899

1.23

1.31

1.5

1.4

ug/g

291.0

281.5

0.19

518

(3015235) Bicarbonate [Moles/volume] in Capillary blood

666

1.27

1.31

2.8

3.1

mmol/l

24.9

25.1

0.17

579

(3050794) Legionella sp Ab [Presence] in Serum

2.50

1.30

1.2

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

231

0.56

1.28

1.2

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3100

30649

1.13

1.27

12.4

10.5

u/l

25.5

26.0

0.72

3035

29545

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

202

1.49

1.27

1.0

ng/l

434.7

324.7

0.83

134

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.05

1.26

1.0

—

(3005033) Fetal Nuchal fold Thickness US

230

0.56

1.26

1.2

1.4

—

(3017569) Oxygen content in Arterial blood

130

1.62

1.26

1.6

2.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

371

1.35

1.25

1.6

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

371

1.35

1.25

1.6

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

220

1.46

1.23

1.4

1.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

717

1.25

1.23

1.7

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

373

1.35

1.22

1.6

1.4

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.63

1.21

1.2

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.83

1.19

1.3

—

(4281824)

347

0.66

1.18

1.0

1.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

117

1.63

1.18

1.3

1.1

—

3.9

—

(40768804) Tissue Pathology biopsy report

1165

12192

0.93

1.17

2.0

2.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.78

1.16

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.00

1.16

2.9

8.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

394

1.32

1.16

1.4

1.6

—

(3021901) Oxygen saturation in Capillary blood

473

1.29

1.16

2.8

2.6

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

1.15

0.0

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

199

1.46

1.14

1.3

1.2

titre

137.0

153.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

1.14

0.0

1.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

770

1.23

1.13

1.4

—

(40761536) Microorganisms panel - Urine sediment

209

2371

0.87

1.12

5.0

3.9

—

(3032057) Clostridioides difficile [Presence] in Stool

1.90

1.12

2.7

2.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.96

1.11

1.7

1.5

ng/l

82.6

110.6

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

168

1.49

1.09

1.1

1.6

u/l

11.5

13.0

0.76

160

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

194

0.57

1.09

1.2

1.1

—

(42870588) Differential panel, method unspecified - Blood

1009

9607

1.07

1.08

6.2

5.9

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.19

1.08

1.3

1.2

umol/24h

2.3

1.7

—

(3007164) IgA [Mass/volume] in Serum or Plasma

569

5301

1.09

1.07

1.4

1.5

g/l

2.3

2.4

0.58

365

3185

(3029075) Extractable nuclear Ab panel - Serum

1.76

1.06

1.0

—

(4015189)

1.76

1.06

3.5

2.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

605

1.25

1.06

1.3

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1055

0.82

1.06

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

279

1.37

1.05

1.2

1.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.12

1.05

1.6

1.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

225

2000

1.13

1.04

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

551

5135

1.09

1.03

1.3

iu/ml

46.7

33.0

1.08

171

1629

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

263

1.37

1.03

4.1

3.8

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

725

1.22

1.03

1.9

1.8

iu/l

2.8

4.9

3.41

267

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

275

0.65

1.01

1.2

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

275

0.65

1.01

1.2

1.4

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

1.89

1.01

1.3

1.2

nmol/l

25.1

27.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

326

2969

1.11

1.00

3.8

3.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

274

0.66

1.00

1.2

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

274

0.66

1.00

1.2

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

547

1.25

1.00

1.2

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

547

1.25

1.00

1.2

1.3

—

(1002224) Polysomnography panel

135

1167

1.16

0.95

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

141

1.49

0.94

1.0

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1738

16897

1.06

0.93

2.9

2.7

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

143

0.56

0.93

1.3

1.5

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

808

1.19

0.93

1.2

u/ml

28.3

42.3

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

150

1.47

0.92

1.3

1.6

ug/l

2.4

5.1

0.71

112

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.72

0.92

1.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

2.14

0.91

1.2

1.3

—

687.9

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.14

0.91

1.0

1.3

—

(3003129) Base excess in Capillary blood by calculation

1.67

0.91

1.2

1.9

mmol/l

1.3

1.5

0.05

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.07

0.89

1.0

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

466

1.25

0.88

1.3

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

289

0.69

0.88

1.0

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

144

1.46

0.87

1.5

1.4

nmol/l

1.2

0.10

112

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.00

0.87

1.5

2.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.72

0.86

1.2

—

(3018010) Neutrophils/100 leukocytes in Blood

1381

13366

1.06

0.85

6.7

5.9

58.1

57.0

2.90

1304

12464

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

1.56

0.84

1.1

1.6

pmol/l

14.7

0.02

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

179

1.40

0.84

1.5

1.6

u/l

5.6

6.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

705

7420

0.94

0.83

3.9

3.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

190

0.63

0.82

1.4

1.7

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.88

0.81

1.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

386

0.75

0.80

1.1

1.0

u/ml

1.1

3.0

2.18

169

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

464

1.23

0.79

1.5

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

592

1.20

0.79

1.3

1.2

u/ml

52.8

42.1

—

(3042631) Mycobacterium sp identified in Specimen

384

1.25

0.78

2.1

2.8

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.50

0.77

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

222

0.67

0.77

1.2

1.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

394

1.25

0.77

1.2

—

(4035726)

250

2731

0.91

0.76

1.4

—

(3000492) Spirometry study

299

2757

1.09

0.76

1.4

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

119

1041

1.15

0.75

1.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

395

1.24

0.75

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

149

1.41

0.75

1.5

1.2

—

(4024509)

290

0.72

0.75

1.8

1.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.57

0.75

1.1

—

(4211845)

132

0.61

0.73

2.6

3.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

288

3118

0.92

0.73

3.5

4.0

ug/l

18.1

25.0

0.35

247

2489

(3025159) Blasts/100 leukocytes in Blood

199

2193

0.90

0.73

3.9

4.2

0.0

0.4

1.00

526

(3024891) Influenza virus A+B Ag [Presence] in Specimen

681

1.18

0.72

1.2

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.61

0.72

1.0

1.1

—

5.7

—

(3002030) Lymphocytes/100 leukocytes in Blood

1394

13546

1.05

0.71

6.8

6.1

27.2

28.1

2.49

1311

12589

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

340

3650

0.92

0.71

5.2

4.5

32.7

32.3

0.23

253

2388

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.92

0.70

1.4

1.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.92

0.70

1.6

2.2

—

(4212803)

1.92

0.70

1.0

1.1

—

(3025130) Human papilloma virus identified in Specimen

364

1.24

0.69

1.6

1.7

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

346

1.25

0.69

2.2

3.4

nmol/l

3.4

22.6

0.64

337

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.85

0.68

1.6

2.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

293

1.27

0.68

1.5

1.8

—

1288.9

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

203

0.69

0.67

5.9

6.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

153

1.37

0.67

2.0

1.3

—

(3037121) Protein [Mass/volume] in Urine

110

969

1.14

0.66

3.5

3.1

g/l

0.2

0.3

0.22

375

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.51

0.66

2.4

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.61

0.65

1.0

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.61

0.65

1.1

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

258

2385

1.09

0.64

4.4

3.9

mmol/l

1.2

1.94

236

2075

(3019069) Monocytes/100 leukocytes in Blood

1358

13218

1.05

0.64

7.0

6.4

8.5

8.6

0.44

1288

12350

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

517

4907

1.06

0.64

1.3

u/ml

14.2

12.5

0.10

217

1892

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

115

1020

1.13

0.63

2.3

1.7

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.52

0.62

1.4

1.5

ug/l

8.9

8.8

0.03

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

102

0.59

0.62

1.2

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

127

1136

1.12

0.61

1.3

iu/l

30.3

34.9

0.78

107

982

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

352

1.22

0.61

2.9

2.3

mg/l

10.9

24.7

3.73

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

504

4788

1.06

0.61

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

844

1.14

0.60

1.9

1.8

—

(3007566) Smooth muscle Ab [Titer] in Serum

741

1.15

0.60

1.2

titre

110.0

97.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

334

0.78

0.60

1.3

1.4

nmol/l

0.7

0.3

0.55

244

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.50

0.59

2.6

2.9

—

(3052592) Norovirus Ag [Presence] in Stool

1.54

0.59

1.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.54

0.59

1.3

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.54

0.59

1.9

1.6

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

593

1.17

0.59

1.2

1.3

u/ml

1.2

3.9

—

(3010813) Leukocytes [#/volume] in Blood

3190

31726

1.09

0.59

28.2

20.4

e9/l

6.9

6.6

9.76

3139

30819

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.45

0.59

1.6

1.8

—

(3007461) Platelets [#/volume] in Blood

3188

31707

1.09

0.58

28.2

20.3

e9/l

253.9

252.7

0.45

3141

30897

(44816559) Phosphatidylethanol [Mass/volume] in Blood

446

1.19

0.58

1.5

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

373

1.21

0.58

1.4

u/l

28.9

32.5

0.32

307

(3045424) Erythrocytes [Presence] in Urine

518

0.83

0.57

1.3

1.6

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

867

1.13

0.57

2.9

3.7

mg/l

97.6

121.9

0.12

703

(3002619) Bacteria identified in Specimen by Culture

1.48

0.57

1.0

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

125

0.64

0.54

2.0

1.7

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.58

0.54

1.0

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.58

0.54

1.0

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.58

0.54

1.0

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

186

1.29

0.54

1.0

1.2

—

(3024731) MCV [Entitic volume]

3188

31717

1.09

0.53

28.1

20.3

91.5

91.2

4.42

3159

31266

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

349

1.21

0.53

1.2

1.5

69.6

56.2

1.56

214

(3035941) MCH [Entitic mass]

3188

31719

1.09

0.53

28.0

20.2

30.5

30.3

3.36

3159

31267

(44813793)

187

1.29

0.52

1.2

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

772

7992

0.96

0.52

1.7

1.6

mmol/l

1.4

0.27

673

6658

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.62

0.52

1.3

1.7

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

146

0.68

0.52

9.5

11.8

nmol/l

1054.5

863.4

—

138

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

1.45

0.51

2.1

1.8

e6/l

800.4

26028.3

—

(3026361) Erythrocytes [#/volume] in Blood

3188

31722

1.08

0.51

28.2

20.3

e12/l

4.4

4.5

16.22

3136

30818

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

260

1.23

0.51

1.1

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.39

0.50

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

868

1.12

0.50

2.9

3.7

mg/l

36.3

63.8

0.96

707

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

346

0.81

0.49

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

324

0.80

0.49

1.5

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

180

1.28

0.49

1.2

1.1

u/l

80.6

77.2

0.12

161

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2887

28646

1.05

0.49

5.0

4.5

mmol/l

4.5

4.8

30.26

2709

26464

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

755

1.13

0.49

1.3

u/ml

4.8

8.6

0.65

126

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

198

1.26

0.49

1.1

1.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

3188

31728

1.08

0.49

28.3

20.4

g/l

133.1

135.1

12.47

3159

31281

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

653

6292

1.05

0.48

4.2

22.4

21.6

0.75

317

3085

(3036071) Salmonella sp Ab [Titer] in Serum

1.40

0.48

1.0

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

700

1.13

0.48

1.7

e6/l

23199.7

12104.8

0.66

504

(3042111) Morphology [Interpretation] in Bone marrow Narrative

484

1.16

0.48

1.4

1.6

—

(3006504) Eosinophils/100 leukocytes in Blood

1344

13152

1.04

0.47

6.8

6.1

2.8

2.9

0.41

1273

12228

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2753

27296

1.05

0.46

15.7

12.7

ml/min/173m2

80.9

79.8

1.96

2391

22507

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

778

1.12

0.46

1.6

1.7

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

210

0.76

0.46

1.8

2.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.43

0.46

3.6

1.5

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

0.61

0.45

1.4

nmol/l

167.1

131.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

301

1.20

0.45

1.2

u/l

42.9

55.6

2.22

211

(3006462) Nitrate [Presence] in Urine

121

0.66

0.45

2.6

3.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

577

0.86

0.44

2.4

1.9

nmol/l

1.0

0.8

1.36

479

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

148

1.29

0.43

2.2

1.5

u/field

4.5

1.8

0.56

109

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.41

0.43

1.1

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

1.61

0.43

1.0

1.3

—

(3022145) Colonoscopy Study observation

350

3333

1.06

0.43

1.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

285

1.19

0.42

1.7

2.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.56

0.42

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

139

0.72

0.42

1.0

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

1.36

0.41

2.0

2.2

e6/l

3928.1

708.6

—

(3013762) Body weight Measured

0.00

0.41

0.0

1.3

—

(3019225) pH of Specimen

312

2966

1.06

0.41

5.8

4.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

786

1.11

0.40

1.2

—

(3005570) Glucose [Moles/volume] in Urine

296

1.18

0.40

2.5

2.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

159

1.26

0.40

1.1

1.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

5.5

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.40

0.0

1.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.0

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

105

0.67

0.39

1.9

1.7

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

160

1.25

0.38

1.1

1.0

—

(3004616) Nuclear Ab [Presence] in Serum

363

1.16

0.38

1.1

1.3

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.39

0.38

1.0

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

742

1.11

0.38

1.3

u/ml

2.0

6.8

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

839

1.10

0.37

2.8

3.7

ratio

3.3

1.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

449

1.14

0.37

1.2

1.3

—

(3022096) Basophils/100 leukocytes in Blood

1302

12782

1.03

0.36

6.9

6.1

0.7

0.89

1228

11892

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.29

0.36

1.1

1.6

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

157

0.76

0.35

1.9

1.4

—

78.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

151

1412

1.07

0.35

1.0

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

264

1.18

0.34

2.4

3.7

61.0

55.8

0.61

174

(3000012) Reticulocyte production index

156

0.77

0.34

1.0

1.6

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2861

28439

1.04

0.34

5.0

4.4

mmol/l

1.4

1.5

11.33

2675

26130

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

265

1.17

0.33

1.6

1.4

nmol/l

1.3

1.5

0.24

240

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

188

0.80

0.33

1.3

1.6

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

173

1.22

0.32

1.1

1.3

—

1.5

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.35

0.32

1.5

1.3

umol/l

16.5

16.6

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

174

1.21

0.31

1.2

1.1

u/l

10.7

19.5

1.45

153

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.32

0.30

1.9

2.7

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.30

0.30

1.1

1.4

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

589

0.90

0.30

3.3

3.6

58.2

57.0

0.28

589

(40757373) Influenza virus identified in Isolate

1.27

0.30

1.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.29

0.30

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

157

1.21

0.29

1.1

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.23

0.29

1.0

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

195

0.82

0.28

2.0

2.4

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

216

0.83

0.28

1.8

1.9

13.3

13.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

270

1.15

0.28

1.3

—

(4094501)

836

1.08

0.27

1.2

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

375

1.12

0.27

1.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

171

0.82

0.26

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

676

0.92

0.26

2.7

2.3

ug/min

81.0

105.5

0.21

399

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

214

0.84

0.26

1.2

1.3

—

(4146454)

319

0.88

0.25

3.3

2.6

—

(3044007) Cell count panel - Peritoneal fluid

1.28

0.24

1.4

1.9

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

138

1453

0.95

0.23

3.4

2.7

e6/l

0.3

0.2

0.06

132

1410

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

265

1.13

0.23

1.2

1.4

27.7

34.7

0.49

157

(3006922) Hepatitis E virus Ab [Presence] in Serum

171

1.17

0.23

1.1

—

(3012441) Differential panel - Pleural fluid

266

1.13

0.22

1.2

1.5

—

(3009871) Measles virus Ab [Titer] in Serum

0.76

0.22

1.4

1.7

—

(40765096) Chromosome analysis panel by Banding

0.75

0.22

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

242

0.87

0.22

1.1

1.0

—

(21494434) Karyotype in Bone marrow

248

1.13

0.21

1.0

1.2

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.0

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

2.5

—

3.5

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.21

0.0

1.3

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

13.5

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.3

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.1

—

(3021589) Normoblasts [#/volume] in Blood

1247

12622

0.98

0.21

10.5

9.5

e9/l

0.0

1.30

1035

10332

(3008898) HLA-B27 [Presence]

906

1.06

0.21

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

11.8

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

293

0.89

0.20

3.8

5.0

u/ml

774.5

73.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.2

—

(3044927) Protein electrophoresis panel - Urine

288

1.11

0.20

1.2

—

(3047189) Immunofixation for 24 hour Urine

133

0.83

0.19

1.1

1.6

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

100

1054

0.95

0.19

2.6

3.5

u/ml

361.5

2501.9

1.11

886

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.15

0.19

1.2

1.3

—

138.0

—

(3004451) EKG impression Narrative

137

1.17

0.18

1.4

1.3

—

(40768441) Liver Pathology biopsy report

213

1.13

0.18

1.5

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

226

2188

1.04

0.18

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

164

0.85

0.18

1.3

1.7

—

(3037756) Immunofixation for Serum or Plasma

570

1.07

0.18

1.3

1.8

—

(3000034) Microalbumin [Mass/volume] in Urine

279

0.90

0.17

3.5

3.1

mg/l

19.0

35.1

0.68

207

(3008536) Aspergillus sp Ab [Presence] in Serum

1.17

0.17

2.7

2.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

774

7853

0.98

0.17

4.5

4.9

ug/l

2.1

2.8

3.30

704

7042

(3013637) Mi-2 Ab [Presence] in Serum

0.71

0.16

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.71

0.16

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.71

0.16

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.71

0.16

1.2

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

282

1.10

0.16

1.2

1.4

e6/l

44520.7

87954.4

0.49

161

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

162

0.86

0.16

1.3

1.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

225

1.11

0.16

2.4

2.0

u/field

1.0

1.6

0.59

(3045142) Bone marrow Pathology biopsy report

331

1.09

0.16

1.2

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.11

0.16

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

235

0.89

0.16

1.2

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

149

1.14

0.15

1.2

1.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

197

1.12

0.15

1.1

1.2

mmol/l

7.9

11.8

—

(3033799) Differential panel - Peritoneal fluid

1.13

0.15

1.0

2.0

—

(3045788) Cell count panel - Pleural fluid

255

1.10

0.15

1.3

1.4

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

188

1.12

0.14

2.3

2.5

e6/l

863.1

637.9

0.42

(3021440) Promyelocytes/100 leukocytes in Blood

225

2310

0.97

0.14

3.7

4.2

0.2

0.1

0.43

611

(3014133) Dog dander IgE Ab [Units/volume] in Serum

295

0.91

0.14

1.1

u/ml

6.7

2.2

—

103

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

439

0.93

0.14

1.2

1.1

iu/ml

79.1

1371.6

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

218

1.10

0.13

1.1

—

(3035880) pH of Pleural fluid

149

0.87

0.13

1.1

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

325

1.08

0.13

1.2

1.4

e6/l

12209.7

2458.6

0.49

234

(40768443) Skin Pathology biopsy report

124

1282

0.97

0.12

1.1

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

231

0.91

0.12

1.1

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

162

1.11

0.11

1.7

1.9

—

10.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

437

1.05

0.10

1.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.11

0.09

1.0

1.4

—

(3013512) EKG study

860

8530

1.01

0.09

4.2

3.7

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.06

0.09

1.4

1.6

pmol/l

9.6

46.0

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

1.11

0.09

1.0

1.4

g/l

768.0

26.0

—

(3035285) Chloride [Moles/volume] in Venous blood

322

1.06

0.08

2.1

2.4

mmol/l

106.3

105.2

0.96

316

(3041354) Potassium [Moles/volume] in Venous blood

322

1.06

0.08

2.1

2.4

mmol/l

3.9

4.0

1.15

316

(3003888) Timothy IgE Ab [Units/volume] in Serum

381

1.05

0.08

1.1

u/ml

2.7

3.3

0.23

177

(3005322) IgE [Units/volume] in Serum or Plasma

182

1786

1.02

0.08

1.4

1.3

u/ml

270.3

193.3

0.70

169

1645

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.08

0.08

1.3

1.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.08

0.08

1.1

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

358

0.95

0.08

1.3

mmol/l

6.4

7.5

2.26

265

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

205

1.07

0.07

1.8

1.3

u/ml

0.3

1.2

0.93

(44806420)

0.84

0.07

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.08

0.07

7.3

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.08

0.07

7.3

2.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

176

1.08

0.07

2.8

2.0

umol/l

8.0

5.9

0.25

117

(3032773) Endomysium IgG Ab [Titer] in Serum

225

1.07

0.07

1.2

1.1

—

(3048879) Bone marrow aspiration report

1.03

0.07

1.0

2.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

651

0.97

0.07

3.3

3.8

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.05

0.07

1.4

1.3

—

(3017704) Immunofixation for Urine

163

0.92

0.07

1.1

1.7

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

739

1.03

0.06

1.1

u/ml

6.3

3.8

—

(3037556) Urate [Mass/volume] in Serum or Plasma

101

0.89

0.06

1.0

1.3

—

(3044941) Cell count panel - Synovial fluid

463

1.04

0.06

1.3

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

356

1.04

0.05

1.2

1.5

g/l

33.8

33.0

0.13

322

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

110

1.09

0.05

1.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

444

0.97

0.04

2.1

3.5

1.4

1.5

0.08

346

(3008401) Mugwort IgE Ab [Units/volume] in Serum

367

1.04

0.04

1.1

u/ml

0.7

1.3

—

144

(3017181) Myelocytes/100 leukocytes in Blood

245

2428

1.01

0.04

3.7

4.2

1.1

0.9

0.61

659

(3015183) Erythrocyte sedimentation rate

139

0.94

0.03

1.0

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

230

0.96

0.03

1.3

1.7

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

440

1.02

0.02

1.0

1.1

—

(3002179) Metamyelocytes/100 leukocytes in Blood

222

2234

0.99

0.02

3.6

4.0

0.7

0.6

0.36

494

(3011412) CD3 cells [#/volume] in Blood

273

1.03

0.01

2.1

2.3

e9/l

1.2

1.1

0.26

173

(3033705) Calcium.ionized [Moles/volume] in Venous blood

314

1.02

0.00

2.2

2.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

394

1.02

0.00

1.1

—

(3021788) Differential panel - Synovial fluid

516

0.99

0.00

1.4

1.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

128

1.02

0.00

1.2

1.4

—

(3024263) Appearance of Synovial fluid

155

0.97

0.00

1.1

1.8

—

(40768806) Pleura Pathology biopsy report

275

1.02

0.00

1.5

1.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

315

1.02

0.00

1.3

1.7

—

(36660697) Celiac disease serology panel - Serum

217

2165

1.00

0.00

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

124

0.97

0.00

2.8

4.6

—

(3002523) Influenza virus A Ag [Presence] in Specimen

396

1.01

0.00

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

434

0.99

0.00

1.1

u/ml

3.6

1.5

0.27

168

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

104

1041

1.00

0.00

1.8

1.7

mg/l

3.2

3.9

0.34

745

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

123

0.98

0.00

3.1

3.3

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

147

1.02

0.00

1.2

1.3

mmol/l

5.9

6.0

0.25

140

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.2

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.0

1.3

—

131.9

—

(3007733) Chloride [Moles/volume] in Urine

0.00

0.0

1.1

—

71.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

6.0

—

0.3

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.2

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

25.8

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.6

—

2.2

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.3

—

2.3

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

150

1.00

0.00

1.6

1.4

umol/l

24.1

25.5

0.06

141

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.85

0.00

1.0

2.6

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

129.9

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

0.95

0.00

2.3

1.7

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.4

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.01

0.00

1.1

1.0

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

0.88

0.00

1.0

1.4

13.5

23.7

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

0.0

3.2

—

8.8

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1270.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_ANEURYSM and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_ANEURYSM	2.021 [1.8, 2.27]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.366

During the follow-up period (1.1.1998 — 31.12.2019), 1412 out of 8126 females with I9_ANEURYSM died.

Males

Parameter	HR [95% CI]	p-value
I9_ANEURYSM	1.977 [1.76, 2.22]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.018

During the follow-up period (1.1.1998 — 31.12.2019), 1268 out of 5324 males with I9_ANEURYSM died.

Mortality risk

Mortality risk for people of age

years, who have I9_ANEURYSM.

N-year risk	Females	Males
1	0.174%	0.347%
5	1.132%	2.357%
10	3.003%	6.196%
15	5.76%	11.634%
20	9.92%	19.211%

Relationships between endpoints

↥

Index endpoint: I9_ANEURYSM – Cerebral aneurysm, nonruptured

GWS hits: 4

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Cerebral aneurysm, nonruptured

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints